OrphoMed
Bay Area, United States · Founded 2015 · $41.8M raised
- Headquarters
- Bay Area, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Total Funding
- $41.8M
- Last Round
- $39.0M Series AMay 2017
- Rounds
- 2
About
OrphoMed is a clinical-stage biopharmaceutical company based in San Francisco, California focused on developing novel first-in-class dimer therapeutics. The company's pipeline targets gastrointestinal conditions including irritable bowel syndrome with diarrhea and opioid bowel dysfunction. OrphoMed received FDA Fast Track designation for its lead compound ORP-101 and reported positive Phase 2 results in 2022.
Summary
OrphoMed is a Biotech company based in Bay Area, United States, founded in 2015. It has raised $41.8M in total across 2 rounds, most recently a $39.0M Series A round in May 2017. Investors include New Enterprise Associates, Takeda (JP) and Pappas Capital.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2017
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/orphomed"><img src="https://indexed.vc/api/badge/company/orphomed" alt="OrphoMed on Indexed.vc" width="260" height="76" /></a>